Aims: Phosphoinositide 3-kinases (PI3Ks) relay growth factor signaling and mediate cytoprotection and cell growth. The cystine/glutamate antiporter system x c -imports cystine while exporting glutamate, thereby promoting glutathione synthesis while increasing extracellular cerebral glutamate. The aim of this study was to analyze the pathway through which growth factor and PI3K signaling induce the cystine/glutamate antiporter system x c -and to demonstrate its biological significance for neuroprotection, cell growth, and epilepsy. Results: PI3Ks induce system x c -through glycogen synthase kinase 3b (GSK-3b) inhibition, general control non-derepressible-2-mediated eukaryotic initiation factor 2a phosphorylation, and the subsequent translational up-regulation of activating transcription factor 4. This pathway is essential for PI3Ks to modulate oxidative stress resistance of nerve cells and insulin-induced growth in fibroblasts. Moreover, the pathway is active in human glioblastoma cells. In addition, it is induced in primary cortical neurons in response to robust neuronal activity and in hippocampi from patients with temporal lobe epilepsy. Innovation: Our findings further extend the concepts of how growth factors and PI3Ks induce neuroprotection and cell growth by adding a new branch to the signaling network downstream of GSK-3b, which, ultimately, leads to the induction of the cystine/glutamate antiporter system x c -. Importantly, the induction of this pathway by neuronal activity and in epileptic hippocampi points to a potential role in epilepsy. Conclusion: PI3K-regulated system x c -activity is not only involved in the stress resistance of neuronal cells and in cell growth by increasing the cysteine supply and glutathione synthesis, but also plays a role in the pathophysiology of tumor-and non-tumor-associated epilepsy by up-regulating extracellular cerebral glutamate. Antioxid. Redox
Introduction

D
ifferent kinds of intracellular stress are relayed through phosphorylation of the eukaryotic initiation factor 2a (eIF2a) by one of the following four eIF2a kinases: protein kinase R (PKR), heme-regulated eIF2a kinase (HRI), PKR-like endoplasmic reticulum kinase (PERK) and general control non-derepressible-2 (GCN2), and subsequent translational up-regulation of activating transcription factor 4 (ATF4) (61) . The mechanism underlying the translational upregulation of ATF4 is based on two upstream open reading frames (ORFs) within the 5¢ untranslated region (5¢UTR) of its mRNA, the second of which overlaps with the ATF4 ORF and inhibits ATF4 protein synthesis when eIF2a phosphorylation is low (22) . The re-establishment of cellular homeostasis by ATF4-induced gene transcription is called the integrated stress response (ISR) (3) .
ATF4 activates the transcription of genes that are involved in amino-acid import, glutathione (GSH) biosynthesis, and resistance against oxidative stress (23) , including xCT mRNA, which encodes the light chain of the amino-acid transporter, system x c - (62) . System x c -imports cystine into cells while exporting glutamate in a 1:1 ratio (64) . Intracellularly, cystine is reduced to cysteine, which is limiting for the synthesis of the important antioxidant GSH (51) . Due to its high concentration, the ratio of reduced GSH to oxidized GSH (glutathione disulfide [GSSG] ) determines the overall intracellular redox state (67) .
We recently reported that the eIF2a/ATF4/xCT signaling module is an important determinant of the oxidative stress resistance of cells (39) . However, in the brain, system x c -might represent a double-edged sword, as its activity increases extracellular glutamate (15) and can, therefore, positively regulate epileptic activity (15) and neurodegeneration (65) .
Strong activation of the ISR reduces protein synthesis (31) , whereas anabolic signaling through growth factors promotes protein synthesis and cell growth. One of the major downstream effectors of growth factors are phosphoinositide 3-kinases (PI3Ks) (48) . On activation, PI3Ks phosphorylate membrane inositol lipids, thereby generating phosphoinositide 3,4,5-triphosphate (PIP3). This is followed by phosphoinositide-dependent kinase 1-induced phosphorylation and activation of Akt, which then phosphorylates and inhibits glycogen synthase kinase 3b (GSK-3b) (13) . In addition to its role in cell proliferation, the PI3K/Akt/GSK-3b pathway has been repeatedly found to be neuroprotective (58, 72) .
Here, we show that the PI3K/Akt/GSK-3b pathway is linked to the activation of the eIF2a/ATF4/xCT signaling module, a connection which is not only important in the proproliferative and neuroprotective effects of PI3K signaling but might also play a role in epilepsy.
Results
The PI3K inhibitor LY294002 sensitizes HT22 cells to oxidative glutamate toxicity through down-regulation of the eIF2a/ATF4/xCT signaling module Recently, we demonstrated that eIF2a phosphorylation is a major determinant of oxidative stress resistance by regulating ATF4 protein levels and system x c -activity (39) . While examining how the eIF2a/ATF4/xCT signaling module is connected to other neuroprotective pathways, we found that the broadspectrum PI3K inhibitor LY294002 (LY) rapidly and dose dependently down-regulates eIF2a phosphorylation and ATF4 in hippocampal HT22 cells (Fig. 1A, Supplementary Fig. 1A ). When transfected with a luciferase (Luci) reporter construct containing the ATF4 5¢UTR and AUG of the ATF4 ORF fused to Luci in a pGL3 backbone (22) , relative Luci activity was decreased by > 50% in HT22 cells that were treated with LY as compared with control cells (Fig. 1B, upper panel) . However, a 24 h treatment with LY did not down-regulate ATF4 mRNA (Fig. 1B, lower panel) . These findings confirm that ATF4 is down-regulated by LY due to decreased translation. Next, we asked whether LY also reduces xCT expression and system x c -activity. A 24 h treatment with LY decreased xCT mRNA expression by *80% and system x c -activity by *50% (Fig. 1C , left panels). Consistent with these observations, we detected an *20% decrease in total GSH levels and an *1.7-fold decrease in the GSH/GSSG ratio on a 24 h treatment with LY (Fig. 1C , middle panels). System x c -expression determines the resistance of HT22 cells to oxidative glutamate toxicity (37, 40) . Correspondingly, LY pre-treated HT22 cells were significantly more sensitive to oxidative glutamate toxicity when measured by the MTT assay (Fig. 1C , right panel) with trypan blue exclusion and visual inspection yielding similar results (Supplementary Fig. S2 ; Supplementary Data are available online at www .liebertpub.com/ars).
To confirm that the observed LY-mediated translational down-regulation of ATF4 is essential for decreased system x c -activity and increased glutamate sensitivity, we used the HT22-derived line HT22R in which a deletion in the second ORF within the ATF4 5¢UTR leads to the expression of a second ORF-ATF4 fusion protein (ATF4 h ) that is not regulated by eIF2a phosphorylation (40) . In HT22R cells, LY suppressed eIF2a phosphorylation but ATF4 h levels did not decrease (Fig.  1D, left panel) . Moreover, LY treatment had no effect on system x c -activity, which depends on ATF4 h in these cells (40) , nor did it increase glutamate sensitivity (Fig. 1D , middle and right panel). Thus, translational down-regulation of ATF4 is a prerequisite for the LY-mediated reduction in system x c -activity and the exacerbation of oxidative glutamate toxicity.
PI3Ka regulates eIF2a phosphorylation and ATF4 levels through inhibition of GSK-3b in HT22 cells LY inhibits several kinases that are related to PI3K (17) . However, intracellular delivery of PIP3 (73) , the PI3K product, and transient over-expression of the constitively active PI3K Innovation Phosphoinositide 3-kinases (PI3Ks) as well as system x c -have been shown to induce cell growth (48) and neuroprotection (36, 58, 70, 72) . In addition, both PI3Ks and system x c -are involved in tumor growth (62, 66) . We show that PI3Ks induce system x c -through general control nonderepressible-2-mediated eukaryotic initiation factor 2a phosphorylation and activating transcription factor 4 translation. The pathway is important for the neuroprotective and growth-stimulatory effects of PI3K activation, is active in glioblastoma cells and, as it is induced by robust neuronal activity in neurons and in human epileptic hippocampi, it might be involved in the pathophysiology of epilepsy.
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p110* (7) increased eIF2a phosphorylation and ATF4 expression ( Fig. 2A, B 2C) . PIK-90 also reduced Luci activity after transfection with the ATF4 5¢UTR Luci reporter construct (Fig. 2D) , verifying reduced ATF4 translation and decreased system x c -activity by *50% (Fig. 2E) . Of note, quantitative polymerase chain reaction (qPCR) showed that HT22 express the p110d subunit of PI3K but not the p110c subunit ( Fig. 2F and Supplementary Fig. S3 ). In combination with the IC 50 s of PIK-90 and TGX221 for the different p110 isoforms, this indicates that PI3Ka determines the activity of the PI3K pathway in these cells, as inhibition of PI3Kc cannot explain the effect of PIK90 because p110c is not expressed and both PI3Kb and d are sensitive to TGX221, which has no effect (Supplementary Table S1 ).
The PI3K pathway leads to the inactivating phosphorylation of GSK-3b (13) . Thus, GSK-3b inhibition should mimic the effect of PI3K activation on the eIF2a/ATF4/xCT signaling module. Indeed, 20 mM lithium chloride (LiCl), a GSK-3b inhibitor (19, 33) , strongly induced eIF2a phosphorylation, ATF4 protein expression (Fig. 3A) , and ATF4 5¢UTR translational activity in the presence as well as the absence of LY; while the effect of LiCl on ATF4 mRNA levels was not significant (Fig. 3B) . Moreover, LiCl increased xCT mRNA expression, system x c -activity, cellular GSH, and survival in response to glutamate (Fig. 3C-F) . Moreover, siRNA-mediated GSK-3b knock-down (Fig. 3G ) and the GSK-3b inhibitors (2¢Z,3¢E)-6-bromoindirubin-3¢-oxime and CT99021 ( Supplementary Fig. S4 ) yielded results similar to those with LiCl. To substantiate the hypothesis that the regulation of system x c -activity is crucial for the PI3K/ GSK3b pathway to influence GSH levels and sensitivity to glutamate, we used mouse embryonic fibroblasts (MEFs) derived from xCT -/ -mice which were stably transfected with xCT driven by a CMV/chicken b actin promoter (pCAGxCT MEFs, see Supplementary Materials and Methods) as previously described for HH514 Burkitt's Lymphoma cells (4) . As expected, 10 lM LY significantly down-regulated system x c -activity in wild-type MEFs, an effect that was more than reversed by 20 mM LiCl, whereas no significant changes in system x c -activity by these two compounds were detected in pCAGxCT MEFs (Fig. 3H) . Matching patterns were observed for GSH levels (Fig. 3I ) and the sensitivity to glutamate (Fig. 3J) , although LY did not exacerbate cell death in both cell lines but LiCl only protected in the wild-type MEFs.
The eIF2a/ATF4 pathway is involved in the neuroprotective as well as the pro-proliferative action of insulin, possibly by regulating the cellular redox potential Insulin signals through the PI3K/Akt/GSK-3b signaling pathway (13) and has been shown to be neuroprotective (26, 72) . In HT22 cells, 100 nM insulin induced eIF2a phosphorylation and ATF4 levels within 2 h (Fig. 4A) . Moreover, insulin robustly induced system x c -activity *2.5-fold on 24 h of exposure (Fig. 4B) . These effects were largely reduced in the presence of LY. The increased x c -activity in response to insulin was accompanied by increased resistance against oxidative glutamate toxicity (Fig. 4C) . Growth factors such as Statistical analysis was performed using two-way ANOVA with Bonferroni's post test with LiCl-treated cells compared with cells with NaCl treatment (A-F) or by comparing Veh/NaCl with Ly/NaCl and Ly/NaCl with Ly/LiCl (H, I) or one-sample t-test compared with 1 (G), *p < 0.05, **p < 0,01, and ***p < 0.001. GSH, glutathione; LiCl, lithium chloride; MEF, mouse embryonic fibroblast; WT, wild type.
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insulin also promote cell proliferation and protein synthesis (57) . In response to insulin, increased GSH synthesis enabled by the induction of the eIFa/ATF4/xCT pathway (39) might lead to a more reduced cellular redox environment, which will, in turn, support cell proliferation (67) . Indeed, the complete absence of the eIFa/ATF4/xCT signaling module in MEFs expressing a genetically engineered eIF2a mutant where the phosphorylation site is inactivated by changing Serine 51 to Alanine (eIF2a S51A ) (68) reversed the growth stimulatory effect of insulin observed in wild-type MEFs (Fig. 4D) . Correspondingly, siRNA-mediated knock-down of ATF4 (40) strongly decreased cell proliferation by *40%, an effect that was completely reversed by augmenting cellular GSH (Fig. 4E) . In addition, knock-down of ATF4 lowered the GSH/GSSG ratio (Fig. 4F) , a change indicative of a more oxidized intracellular redox environment (67).
GCN2-mediated eIF2a phosphorylation is essential for the regulation of ATF4 and system x c -activity via PI3K/GSK-3b signaling, while nuclear factor (erythroid-derived 2)-like 2 is not involved PI3K has been reported to up-regulate the nuclear factor (erythroid-derived 2)-like 2 (Nrf2) (11, 30) , which also upregulates xCT mRNA expression and, thus, system x c -(63). However, LY did not down-regulate basal Nrf2 levels in HT22 cells (Fig. 5A) . To further examine whether the PI3K/Akt/ GSK-3b pathway depends on eIF2a phosphorylation or Nrf2 to regulate system x c -activity, we used MEFs derived from Nrf2 knock-out ( -/ -) mice (63) and the eIF2a S51A MEFs. Consistent with previous findings that both Nrf2 and eIF2a phosphorylation induces xCT expression (36, 39) , basal system x c -activity was reduced to *41% and *8% of control activity in Nrf2
-/ -and eIF2a S51A MEFs, respectively (Fig. 5B , -/ -and GCN2 + / + MEFs treated as in (C) with total eIF2a as a loading control. (E) GCN2 phosphorylation as a surrogate marker for its activity. HT22 cells were treated as indicated in (C), and then, cell lysates were prepared and GCN2 was immunoprecipitated with a rabbit GCN2 antibody and protein A-Sepharose. The immunoprecipitates were blotted with either an antibody to phospho-GCN2 (p-GCN2) or an antibody to total GCN2 (GCN2). (F) Regulation of system x c -activity, total GSH, and resistance against oxidative glutamate toxicity by the PI3K/GSK-3b pathway in GCN2
-/ -compared with GCN2 + / + MEFs. After a 24 h treatment with PI3K inhibitors and LiCl as in (B) system x c -(left panel) and total GSH (middle panel) were measured. Relative system x c -activity and relative total GSH in GCN2
-/ -compared with GCN2 + / + was 79% and 109%, respectively. (right panel) GCN2 -/ -and GCN2 + / + MEFs were seeded onto 96-well plates and after 24 h, they were treated with indicated concentrations of glutamate for 24 h before survival was quantified by the MTT assay. Mean survival of GCN2
-/ -was 74.1% at 2.5 mM glutamate, while GCN2 + / + MEFs showed 70% viability at 50 mM ( Supplementary Fig. S5 ). Relative effect on survival of LY and LiCl at these glutamate concentrations (GCN2 + / + MEFs 50 mM, GCN2 -/ -MEFs 2.5 mM). The graphs represent the mean -SEM of three [(F), left panel], four [(F), middle and right panel], five (A), or four to six independent experiments (B). The non-quantified Western blots show representative results from at least three independent experiments. Statistical analysis was performed by a onesample t test (A), one-way ANOVA (B), or two-way ANOVA (F) with Bonferroni's post tests;*p < 0.05, **p < 0.01, and ***p < 0.001. GCN2, general control non-derepressible-2; HRI, heme-regulated eIF2a kinase; Nrf2, nuclear factor (erythroidderived 2)-like 2; PERK, PKR-like endoplasmic reticulum kinase; PKR, protein kinase R.
2 VIA EIF2a and ATF4 2913 left panel). Both PIK-90 and LY suppressed and LiCl rescued the LY effect on system x c -activity equally in wild-type and Nrf2
-/ -MEFs (Fig. 5B, right panel) . In contrast, in eIF2a
S51A
MEFs, no changes in system x c -activity were detected with any of these compounds.
We next asked how the PI3K/Akt/GSK-3b and eIF2a/ATF4/ xCT pathways were connected. LY down-regulated and LiCl increased ATF4 expression in MEFs from wild-type, PKR -/ -, PERK -/ -, and HRI -/ -mice, whereas this effect was completely abolished in MEFs deficient in the eIF2a kinase GCN2 (Fig. 5C ). Phosphorylation of eIF2a was reduced by LY and increased by LiCl in wild-type MEFs, but no response to either of these treatments was seen in GCN2 -/ -MEFs (Fig. 5D) . Activation of GCN2 leads to its autophosphorylation (60) . In HT22 cells, GCN2 phosphorylation was decreased by LY and increased by LiCl (Fig. 5E) . Downstream, the suppression of system x c -activity by either PIK-90 or LY was largely reduced in GCN2 -/ -
MEFs compared with GCN2
+ / + MEFs and the opposing effect of LiCl was even reversed. A similar pattern was observed for total GSH in response to LY and LiCl (Fig. 5F ). GCN2
-/ -cells were considerably more sensitive to glutamate. When glutamate concentrations were used that led to a similar *70% survival (50 mM for GCN2 + / + , 2.5mM for GCN2 -/ -MEFs, see Supplementary Fig. S5 ), the effect of LY on viability was significantly less in GCN2
-/ -MEFs compared with wild-type MEFs, and again, the protective effect of LiCl was missing and even reversed in GCN2
-/ -MEFs. Taken togeter, these data show that Nrf2 is dispensable, whereas eIF2a phosphorylation is essential for the regulation of system x c -by PI3K/Akt/GSK-3b signaling under the experimental conditions employed in the present study and connected to PI3K/Akt/GSK-3b signaling via GCN2.
PI3Ks regulate xCT expression and system x c -activity via eIF2a phosphorylation and ATF4 in glioblastoma cells Glioblastomas are highly malignant brain tumors in which the PI3K pathway is frequently hyperactive (16) , and both ATF4 (6) and xCT (65) have been found to be up-regulated.
Increased system x c -activity in glioblastomas has been linked not only to invasive growth but also to tumor-induced epilepsy (9, 63-66, 72, 74) . Indeed, as described for regular glioma cell lines (12, 53) , pharmacological inhibition of system x c -activity by two structurally different inhibitors, sulfasalazine and (S)-4-carboxyphenylglycine, also reduced proliferation of serumdifferentiated cells derived from glioblastoma-initiating cancer stem cell line G38 (Supplementary Fig. S6 ). In these cells and a similarly generated cell line, G35, (5), LY-mediated PI3K inhibition down-regulated eIF2a phosphorylation, ATF4 protein levels, and system x c -activity (Fig. 6) , indicating that the PI3K pathway is involved in the activity of the eIFa/ATF4/xCT signaling module in glioblastoma cells in vitro.
High-frequency neuronal activity up-regulates system x c -activity via the PI3K/Akt/GSK-3b/eIF2a/ATF4 pathway in primary cortical neurons
In glioblastoma patients, not only was high tumor xCT expression found to be associated with epileptic seizures but also xCT up-regulation in the peritumoral tissue was associated with epilepsy (75), possibly indicating epilepsy-induced changes of the affected brain tissue. To test this hypothesis, we induced high-frequency discharges, as found in epilepsy, in rat cortical neurons using the GABA A receptor antagonist bicuculline (Bic) plus the K + channel blocker 4-aminopyridine (Bic/4-AP) (24) . Bic/4-AP was reported to activate the PI3K/Akt/GSK3b pathway through synaptic N-methyl-D-aspartate receptors in this paradigm (2, 54) . Bic/4-AP led to a robust and LY-sensitive increase in system x c -activity as well as xCT mRNA abundance (Fig. 7A, B) . In addition, the GSK-3b inhibitor CT99021 increased xCT mRNA levels (Fig. 7C) . The up-regulation of xCT mRNA did not depend on Nrf2, as the Bic/4-AP-mediated induction of xCT mRNA was fully preserved in Nrf2 -/ -neurons (Fig.  7D) . In contrast, Bic/4-AP treatment significantly increased ATF4 protein levels in an LY-sensitive manner (Fig. 7E ) and stimulated the translational activity of the 5¢UTR of ATF4 (Fig. 7F) , indicating increased ATF4 protein translation induced by eIF2a phosphorylation. Moreover, the Bic/4-AP-induced xCT promoter activity in neurons transfected with an xCT 
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promoter-Luci reporter was suppressed when co-transfected with a dominant-negative ATF4 mutant (Fig. 7G) .
The PI3K/Akt/GSK-3b/eIF2a/ATF4/xCT pathway is activated in hippocampi from patients with temporal lobe epilepsy Next, we asked whether the new pathway described here is up-regulated in human hippocampal tissue samples from patients with temporal lobe epilepsy (TLE) obtained during lobectomy. Hypothetically, this should be followed by an increase in extracellular glutamate that is known to decrease the epileptic threshold (15) . Indeed, Akt and GSK-3b phosphorylation in epileptic tissue was strongly increased compared with autoptic control hippocampi (Fig. 8A) . This was associated with a significant increase in eIF2a phosphorylation and ATF4 and xCT protein expression. Linear regression analysis testing the relationship of the four pairs of connected parts of the pathway across the whole group of samples showed positive results for all pairs (Fig. 8B) . Importantly, neither Akt, GSK-3b, and eIF2a phosphorylation nor ATF4 and xCT expression were influenced by the postmortem interval in the control group (Fig. 8C) .
Discussion
The results of the present study tie together two apparently functionally disparate signaling pathways, namely, the PI3K/ Akt/GSK-3b pathway and the eIF2a/ATF4/xCT signaling module (Fig. 9) . Inhibition of the first pathway by two independent inhibitors, LY and PIK-90, down-regulated the second signaling module. Activation of the PI3K/Akt/GSK-3b 
PI3KS UPREGULATE SYSTEM X C
2 VIA EIF2a and ATF4pathway by insulin, over-expression of a constitutively active PI3K, or mimicking its activation by PIP3, three different GSK3b inhibitors or GSK-3b knock-down yielded the opposite results. Moreover, in cells unable to phosphorylate eIF2a, the regulation of system x c -activity by manipulation of the PI3K/Akt/GSK-3b pathway was completely lost. We found evidence of this new connection in cells as diverse as hippocampal HT22 cells, MEFs, glioblastoma cells, and primary neurons and present data strongly supporting the hypothesis that this pathway is responsible for up-regulating xCT expression in the human epileptic hippocampus.
The link between the PI3K/Akt/GSK-3b pathway and the eIF2a/ATF4/xCT signaling module is the eIF2a kinase GCN2. This conclusion was drawn from three lines of evidence. First, in HT22 cells, manipulation of the PI3K/Akt/ GSK-3b pathway changes GCN2 autophosphorylation, a surrogate marker for its activity (60) , consistent with the observed changes in eIF2a phosphorylation and ATF4 protein levels. Second, the regulation of ATF4 through the PI3K/Akt/GSK-3b pathway is selectively lost in GCN2-deficient cells. Third, the regulation of system x c -activity in GCN2-deficient cells through the PI3K/Akt/GSK-3b pathway is largely reduced. Classically, GCN2 is activated not only by uncharged tRNAs when amino acids are in limited supply (32) but also by UV radiation (29) . Thus, our findings describe a new role for this eIF2a kinase. However, how the PI3K/GSK-3b pathway regulates GCN2 activity remains to be determined.
FIG. 8.
The PI3K/GSK-3b/eIF2a/ATF4/xCT pathway is activated in human epileptic hippocampal tissue. Protein extracts from surgical specimens from human epileptic hippocampi (Epilepsy) and control hippocampi (Control) were tested for the relative phosphorylation of Akt (phospho-Akt), GSK-3b (phospho-GSK-3b), and eIF2a (phospho-eIF2a) as well as ATF4 and xCT expression by Western blotting. Either antibodies that recognize the proteins irrespective of their phosphorylation state (total) or actin were used as loading controls. (A) Representative blots are shown. Longer exposures than those shown were used for the quantification of some of the samples. Graphs show the quantitative results with epileptic (Epi) compared with control (Ctrl) tissue with the mean value of the control group normalized to 1. For eIF2a phosphorylation, one sample (Epi sample 2, p-eIF2a/eIF2a = 55.8) was excluded, as this value was classified as an extreme outlier (see the ''Materials and Methods'' section). Statistical analysis was performed by one-tailed Student's t tests, ***p < 0.001, **p < 0.01, and *p < 0.05. (B) Pair-wise linear regression of the four pairs of connected parts of the pathway across the whole group of samples (Epi sample 2 excluded). The goodness of fit is given in the graphs. The slope was significantly different from zero in all cases (GSK-3b/pAkt, p < 0.001; p-eIF2a/p-GSK-3b and ATF4/p-eIF2, p < 0.01; xCT/ATF4, p < 0.05). (C) Relationship of Akt, GSK-3b and elF2a phosphorylation and ATF4 and xCT expression with the postmortem interval in control hippocampi.
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To our knowledge, the observation that the eIF2a/ATF4/ xCT signaling module is modulated by the PI3K pathway has not been previously recognized. However, that insulin can up-regulate ATF4 protein levels has been described (1, 27, 47) . Similarly, macrophage colony-stimulating factor, which also binds to a receptor tyrosine kinase (8), induced LY-sensitive ATF4 up-regulation in osteoclasts (10) . However, two of these reports concluded that the observed increase in ATF4 protein is mediated by reduced degradation (10, 27) .
Downstream of eIF2a and ATF4, the new pathway connects PI3K signaling with the expression of the specific subunit of the cystine/glutamate antiporter system x c -, xCT, and, therefore, GSH metabolism. Insulin was reported to induce system x c -in human fibroblasts (43) . Moreover, system x c -activity has been shown to be up-regulated by other factors that activate the PI3K/Akt/GSK-3b pathway, including erythropoietin (70), insulin-like growth factor 1 (55), and fibroblast growth factor 2 (42). Whether these observations are explained by the pathway described in the present study should be determined.
Of note, Nrf2, the other transcription factor that stimulates xCT expression (63) , has been shown to be up-regulated though the activation of the PI3K/Akt/GSK-3b pathway (11, 35, 59) by inhibiting proteasomal degradation which is initiated by b-TrCP after GSK-3b-mediated Nrf2 phosphorylation. However, the impact of GSK-3b on Nrf2 may not be pronounced when Nrf2 degradation is directed by the ''classical'' pathway through Keap1 [see ref. (50)]. At present, it is unclear what dictates the relative importance of the two pathways. At least in HT22 cells, we found that basal Nrf2 protein levels are unaffected by PI3K inhibition. Moreover, our data showing that the regulation of system x c -activity by the PI3K/Akt/ GSK-3b pathway as well as the up-regulation of the xCT mRNA in response to high-frequency discharges are preserved in Nrf2 -/ -MEFs and primary neurons, respectively, excluding Nrf2 as a major regulator of system x c -through the PI3K/Akt/GSK-3b pathway under the experimental conditions employed in our study.
The connection between the PI3K/Akt/GSK-3b pathway and the eIF2a/ATF4/xCT signaling module has functional consequences at least in vitro, because through this connection cellular GSH levels and the sensitivity of cells to oxidative glutamate toxicity are regulated. The transcriptional regulation of xCT by the PI3K/GCN2/eIF2a/ATF4 is essential for the pathway to influence cellular GSH and resistance against oxidative stress, as cells expressing xCT that were driven by b actin promoter did not show any difference in GSH or cell death in response to oxidative glutamate toxicity when this pathway was manipulated pharmacologically. This suggests that the PI3K/Akt/GSK-3b/GCN2/eIF2a/ATF4/xCT pathway might be relevant for the cytoprotective consequences of PI3K activation, including neuroprotection against diverse insults (58, 72) although direct evidence for neuroprotective action of xCT induction in vivo is lacking, and it plays a role in the malignant transformation and chemoresistance of tumor cells (21, 62) . However, in addition to GSK-3b inhibition and subsequent neuroprotection via the pathway described here, Akt activation has been described to be neuroprotective by inducing BAD phosphorylation (69) and activation of the mammalian target of rapamycin (41) . Due to its high concentration in cells, the GSH/GSSG redox couple determines the general redox environment of cells with a more reduced redox state that is linked to proliferation (67) . ATF4 knock-down shifted the GSH/GSSG redox couple to a more oxidized state while inhibiting cell proliferation in a GSH-sensitive manner. Moreover, we show that insulin loses its growth-stimulating effect in fibroblasts lacking eIF2a phosphorylation. These findings strongly support the view that the eIF2a/ATF4/xCT signaling module is an essential constituent of the pro-proliferative machinery downstream of growth factor signaling by keeping the cellular redox potential in a reduced, growth-permissive state. This finding is surprising, as eIF2a phosphorylation has been viewed as a mechanism that reduces protein translation, and therefore growth, in response to cellular stress [reviewed in ref. (56)]. Thus, our data indicate that the formerly accepted role of eIF2a phosphorylation may be overly simplistic and applied only to very high levels of eIF2a phosphorylation.
Glioblastomas exhibit increased PI3K signaling (34), ATF4 (6) and xCT expression (65) . The latter has been associated with invasive growth (44) and poor outcome (74) as well as with tumor-induced seizures that are possibly generated by system x c -mediated glutamate release (9, 75) . Our data show that the connection between the PI3K/Akt/GSK-3b pathway and the eIF2a/ATF4/xCT signaling module is active in human glioblastoma cells which are derived from glioblastoma-initiating cancer stem cells. Thus, PI3K signaling might induce xCT expression via the eIF2a/ATF4 signaling module in glioblastomas and, therefore, tumor-associated seizures. Importantly, the eIF2a/ATF4/xCT branch of PI3K signaling that we describe might also explain other types of seizures. We show that this pathway is also induced by bursts of action potentials as found in epilepsy in primary neurons and in human epileptic hippocampi when compared with non-epileptic controls. Of note, since our control samples were derived from autopsy material and compared with biopsies obtained during lobectomy of the TLE patients, we FIG. 9. Summary of the new pathway and the experimental evidence supporting it. Activation is depicted as arrows, inhibition as u, kd: siRNA-mediated knock down.
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cannot exclude changes in protein phosphorylation or expression due to the different tissue handling. However, since these data are highly consistent with the in vitro results and we found no association of the markers examined with the postmortem interval in control tissues, we assume that this potential bias is negligible. Thus, we hypothesize that activation of the PI3K pathway in response to epileptic discharges might result in pro-epileptic molecular changes via induction of eIF2a phosphorylation, ATF4 protein expression, and, finally, up-regulation of system x c -and, therefore, glutamate release.
Materials and Methods
For materials, see Supplementary Materials and Methods.
Human samples
Epileptic patients underwent resection of the hippocampus for medically intractable TLE and were neuropathologically diagnosed to have hippocampal sclerosis of Wyler grade 3 (18) (Supplementary Table S2 ). Control hippocampal tissue was obtained at autopsy from patients without a history of seizures. There were no significant differences in sex distribution or age between the two groups. Informed consent was obtained for the use of brain tissue and for access to medical records for research purposes. All samples were obtained and used in a manner that was compliant with the Declaration of Helsinki.
Cell culture HT22 cells were grown in high-glucose Dulbecco's modified Eagle medium (DMEM) (Invitrogen) that was supplemented with 10% fetal calf serum (FCS; Hyclone) as described earlier (14) . For viability assays, 2.5 · 10 3 HT22 cells, 5 · 10 3 GCN2 + / + , 1 · 10 4 GCN2 -/ -, and 1 · 10 3 wild-type and pCAGxCT MEFs were plated in 96-well plates with LY, PIK-90, TGX-221, insulin, CT99021, or LiCl or vehicle or, in the case of LiCl, NaCl. In the case of HT22 cells treated with insulin and CT99021, the serum concentration was reduced to 0.5%, for wild type, and pCAGxCT MEFs medium cystine concentration had to be reduced to 50 lM to induce cell death in pCAGxCT MEFs. After 24 h of culture, the medium was exchanged with fresh medium without the respective compound, and the indicated concentrations of glutamate for 24 h before viability were quantified by the MTT assay as described earlier (38 MEFs from John Bartlett and Megan Sierant (Forsyth Institute). pCAG-xCT MEFs were generated as described in the ''Supplementary Materials and Methods'' section. MEFs were propagated in high-glucose DMEM (Invitrogen) with 10% FCS (Hyclone) that was additionally supplemented with essential and non-essential amino acids (Invitrogen). Cells were replated for no more that 10 passages by trypsinization when confluent. Glioblastoma-initiating cancer stem cells derived from surgical specimens were grown as described (5) . The use of material for cell cultures was approved by the ethics committee, Medical Faculty, University of Ulm, and informed consent was obtained from the patients before surgery. G35 and G38 glioblastoma-initiating cancer stem cells were differentiated by culture in DMEM (GIBCO by Life Technologies) that was supplemented with 10% FCS (GIB-CO), and stem cell-derived glioblastoma cells were passaged by trypsination for approximately 20 times.
Cortical neurons from E21 Sprague-Dawley rats were cultured as described earlier (2), and mouse cortical neurons from E17.5 Nrf2
+ / + and Nrf2 -/ -mice were cultured as described (20) . The Nrf2 -/ -mice were kindly provided by Masayuki Yamamoto of the University of Tsukuba (now University of Tohoku). In both cases, neurons were cultured in growth medium consisting of Neurobasal A that was supplemented with B27 (Invitrogen), 1% rat serum (Harlan SeraLab), and 1 mM glutamine (Sigma-Aldrich). To obtain astrocyte-free neuronal preparations ( > 98% NeuN-positive neurons and < 0.2% GFAP-positive astrocytes), cultures were treated with the anti-mitotic cytosine-arabinoside immediately post-plating. Experiments were performed after 8-10 days in vitro (DIV). Before stimulation, neurons were transferred to a trophically deprived medium containing 10% Minimum Essential Medium (Invitrogen) and 90% Salt/Glucose/Glycine medium consisting of: 114 mM NaCl, 32.7 mM NaHCO 3 , 5.292 mM KCl, 1 mM MgCl 2 , 2 mM CaCl 2 , 10 mM HEPES, 1 mM glycine, 30 mM glucose, 0.5 mM sodium pyruvate, and 0.1% phenol red; osmolarity 325 mOsm/L (2) and allowed to equilibrate for at least 3 h. Bursts of action potentials were induced through stimulation with 50 lM Bic and 250 lM 4-AP for typically 24 h (24) unless stated otherwise.
Transfection and luciferase reporter assays
For luciferase (Luci) reporter assays, HT22 cells were transfected with a pSV-b-galactosidase (Gal) plasmid (Promega) and a vector containing the ATF4 5¢UTR and AUG fused to Luci by the TK promoter in a pGL3 backbone (22) (a generous gift from David Ron, Metabolic Research Laboratories, University of Cambridge) as previously described (40) . When using a pcDNA3.1-EGFP construct and 4¢,6-diamidino-2-phenylindole to visualize nuclei, the transfection efficacy was 72.7 -8.9% (not shown). Twenty-four hours after transfection, cells were treated with the indicated compounds for 24 h. Next, cells were lysed, and Luci and Gal enzyme activities were measured as previously described (39) . For siRNA transfection, HT22 cells were plated in 60 mm dishes at 5 · 10 5 cells/dish and 20 pmol ATF4 siRNA (#sc-35113), GSK-3b siRNA (#sc-35525), or control siRNA (#sc-37007), all from Santa Cruz Biotechnology, were used along with Lipofectamine 2000 as previously described (40) . Neurons were transfected at DIV 8 using Lipofectamine 2000 as described (2) . For xCT-Luci assays, 0.1 lg pTK-Renilla (Promega), 0.2 lg pGL3-4.7 xCT promoter Luci reporter plasmid (63) (a kind gift from Hideyo Sato, Yamagata University), and 0.3 lg of a b-globin control plasmid [a gift from Richard Maurer, Oregon Health Sciences University (71)], or plasmids encoding ATF4 (39) or a dominant negative ATF4 mutant [a gift from Jawed Alam, Ochsner Medical Center (25)] were used. To assay ATF4 5¢UTR-mediated translation, the ATF4 5¢UTR Luci reporter was co-transfected with the pTK-Renilla plasmid (22) . Twenty-four hours after transfection, neurons were stimulated as indicated. Luci assays were performed using the Dual Glo assay kit (Promega) with Firefly Luci reporter gene activity normalized to Renilla control.
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Enzymatic measurement of GSH
To measure GSH, 1.65 · 10 5 HT22 cells were plated in 60 mm dishes and grown in the presence of 10 lM LY or vehicle for 24 h. Total GSH was measured as described (45) . To measure the GSSG/GSH ratio, the GSH/GSSG-Glo Assay kit (Promega) was used.
Measurement of system x c -activity 3 · 10 4 HT22 cells were seeded into 24-well plates and treated with LY, LiCl or NaCl, or insulin for 24 h and PIK-90 for 15 h. System x c -activity after 24 h of PIK-90 exposure returned to normal levels (data not shown), either due to instability of the compound or due to up-regulation of PI3Ks other than PI3Ka. For insulin and CT99021, FCS concentration was reduced to 0.5%. 6 · 10 4 eIF2a S51A MEFs, Nrf2 -/ -, GCN2
-/ -MEFs, or control MEFs with or without 10 lM LY, 1 lM PIK-90, or vehicle (dimethylsulfoxide) with 20 mM LiCl or NaCl were grown for 24 h. For pCAGxCT MEFs and controls, the number was reduced to 3 · 10 4 . In experiments including eIF2a S51A and Nrf2 -/ -MEFs, extra amino acids and 1 mM GSH were added to the growth medium to prevent artifacts due to reduced amino-acid availability or GSH levels as a results of the genotype. G35 and G38 glioblastoma cells were seeded at a density of 1 · 10 4 cells per cm 2 cells per well in 24-well plates that were coated with poly-l-lysine. Cells were washed thrice with sodium-free Hank's buffered salt solution (52) . System x c -activity was measured as sodium-independent, homocysteic acid-inhibitable uptake of 3 H-glutamate (Perkin Elmer NEN) as previously described (39) . Primary cortical neurons stimulated in 90% Salt/Glucose/Glycine medium for 24 h were transferred to Na + -free Krebs' solution (containing 120 mM choline chloride, 25 mM Tris, 5 mM KCl, 1 mM K 2 HPO 4 , 1 mM MgCl 2 , 2 mM CaCl 2 , and 30 mM glucose). Then, 1 lCi/ml 3 H-glutamate (Perkin Elmer NEN) was added to solution in the presence or absence of 1 mM cystine and cells were incubated for 30 min at 37°C. Cells were subsequently washed twice in ice-cold Na + -free Krebs' solution and lysed in K 2 HPO 4 buffer containing 0.5% Triton. Radioactivity of lysates was measured using a scintillation counter, with a portion of the lysate used to determine protein concentration using the Bradford or bicinchoninic acid method (both from Pierce) for normalization purposes. System x c -activity was calculated as sodium-independent cystine-inhibitable 3 Hglutamate uptake.
Subcellular fractionation and preparation of protein samples
Subcellular fractionation and the preparations of protein samples was performed as previously described (46, 49) with minor modifications; for details, see the ''Supplementary Materials and Methods'' section.
Western blotting
Western blotting was performed as previously reported (5, 39) and described in detail, including the primary antibodies and dilutions in the ''Supplementary Materials and Methods'' section. The specificity of the ATF4 and Nrf2 bands detected by both of these antibodies was extensively characterized previously ( Supplementary Fig. 1B) [see ref. (40)]. For relative eIF2a and GSK-3b phosphorylation, parallel blots were performed. For all other antibodies, the same membrane was re-probed for actin or the antiserum reacting with the total protein produced in a different species from the phospho-specific antibody. Relative ATF4 and xCT expression was normalized to actin band density. For cellular extracts, each Western blot was repeated with at least three independent protein samples.
RNA preparation, reverse transcription, and qPCR
Total RNA from HT22 cells was isolated using the RNAeasy mini kit (Qiagen). qPCR that was used to quantify ATF4 and xCT mRNA expression was performed as previously described (40) . For primers used for qPCR for the cDNAs encoding the four p110 isoforms, see the ''Supplementary Materials and Methods'' section. RNA from primary cortical neurons was prepared using the Roche isolation reagents, including a 15 min DNase I treatment to avoid genomic DNA contamination of samples (Roche). cDNA was synthesized using the Transcriptor One-Step RT-PCR Kit (Roche). qPCR was performed in an Mx3000P qPCR System (Stratagene; Agilent Technologies) using 2 · FastStart Universal SYBR Green Master Mix (Roche) according to the manufacturer's instructions. Expression of the gene of interest was calculated using the efficiency corrected DDCt method, normalizing to either GAPDH or 18S ribosomal RNA as housekeeping genes. For primers used for qPCR for cDNA derived from primary neurons, see the ''Supplementary Materials and Methods'' section.
Statistical analysis
Data from at least three independent experiments were normalized, pooled, and analyzed using Graph Pad Prism 4 software followed by appropriate statistical tests. For exclusion of outliers, the established definition of an extreme outlier was used as follows: values lower or higher than the 25% percentile (Q1) or 75% percentile (Q3) minus or plus three times the interquartile range (Q3-Q1), respectively.
